A Long-term Follow-up Study of Patients Who Received VOR33

A Long-term Follow-up Study of Patients Who Received VOR33
Condition:   Leukemia, Myeloid, Acute
Intervention:   Genetic: VOR33
Sponsor:   Vor Biopharma
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 13, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments